|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/37 | |
| A61K 35/14 |
| (11) | Number of the document | 2635297 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11838863.6 |
| Date of filing the European patent application | 2011-11-04 | |
| (97) | Date of publication of the European application | 2013-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/059297 |
| Date | 2011-11-04 |
| (87) | Number | WO 2012/061689 |
| Date | 2012-05-10 |
| (30) | Number | Date | Country code |
| 410437 P | 2010-11-05 | US |
| (72) |
LAI, Chee Kong, US
STAFFORD, Roddy, Kevin, US
|
| (73) |
Baxalta Incorporated,
1200 Lakeside Drive, Bannockburn, IL 60015,
US
Baxalta GmbH, Zählerweg 4, 6300 Zug, CH |
| (54) | A NEW VARIANT OF ANTIHEMOPHILIC FACTOR VIII HAVING INCREASED SPECIFIC ACTIVITY |
| A NEW VARIANT OF ANTIHEMOPHILIC FACTOR VIII HAVING INCREASED SPECIFIC ACTIVITY |